Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
  • Peer groups
    • HR Peer Group
    • Recruitment Peer Group
    • Marketing Peer Group
    • PA Peer Group
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job
    • Peer groups
      • HR Peer Group
      • Recruitment Peer Group
      • Marketing Peer Group
      • PA Peer Group

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Yourgene Health Logo
    12 November 2026

    Yourgene Health Insight DPYD Assay secures TGA regulatory approval in Australia

    Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces Australian regulatory approval for its Yourgene® Insight DPYD assay. The approval enables Southern Cross Diagnostics Pty ...

    Winterlight speech assessment launched on CANTAB Connect Research
    12 November 2026

    Launch of Winterlight™ speech assessment for academic research

    Cambridge Cognition (AIM: COG), the neuroscience technology company, announces the launch of Winterlight™ speech assessment to academic researchers through the CANTAB Connect Research platform. Researchers can now add Winterlight™ speech tasks alongside CANTAB® touchscreen tasks, questi...

    Dr Stephen Hoole, Consultant Cardiologist, Royal Papworth Hospital	Dr Simon Williams,  General Manager, PlaqueTec
    12 November 2026

    PlaqueTec’s BIOPATTERN trial passes 100 patients and expands to 8 NHS centres

    PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to reveal the biological drivers of atherosclerotic cardiovascular disease (ASCVD), today announced that its BIOPATTERN clinical trial has recruited its 100th patient and expanded to eight NHS specialist cardiac centres...

    group of people
    13 November 2026

    Applications open for University of Cambridge’s Impulse entrepreneurship programme

    Applications are now open for the 2027 Impulse Programme, the flagship entrepreneurship programme of the Maxwell Centre at the University of Cambridge, helping early-stage science and technology innovators turn promising ideas into viable businesses. ...

    Barton House, Abingdon Science Park
    11 November 2026

    T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford

    Newly built facility delivered by Kadans Science Partner at Barton House will support company growth and progression of novel T cell engager pipeline programmes ...

    Dr. Jonathan Appleby Chief Scientific Officer, Mogrify  and Joe Foster Chief Executive Officer, Mogrify
    11 November 2026

    Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

    Preclinical proof-of-concept data will be presented at the FLORetina-ICOOR 2026 Congress, taking place from 3 - 6 December 2026Data demonstrate that MOGRIFY-derived transcription factors can preserve and restore functional vision in a rodent model of photoreceptor degenerationCambridge,...

    New treatment for patients in prolonged cardiac arrest outside hospital successfully deployed in pilot study by East Anglian Air Ambulance
    11 November 2026

    New treatment for patients in prolonged cardiac arrest outside hospital successfully deployed in pilot study by East Anglian Air Ambulance

    Procedure performed in pre-hospital emergency care situations for first time now warrants further investigation into patient survival outcomes. A pioneering study led by researchers and clinicians from East Anglian Air Ambulance has demonstrated that a procedure usually used in hospital...

    castor bean tick (Ixodes ricinus)
    10 November 2026

    Lyme disease vaccines: a second chance for the US market

    VacZine Analytics, a specialist publisher in vaccines, has released a new independent commercial forecast for Lyme disease vaccines in the United States, as the most advanced Lyme disease vaccine candidate progresses through regulatory review. ...

    The Lab Thread Research Lab Management Software
    10 November 2026

    Lab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

    · New MCP server connects external AI tools directly to structured laboratory data, with no exports or custom integrations required· Suite of AI functions address key data bottlenecks in biological research labs, from protocol writing to equipment set-up· The launch also marks Lab ...

    Stuart Rose, CEO, BioUK Neil Roberts, MD, SEHTA
    9 November 2026

    BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

    Asset acquisition combines BioUK’s strength in biotech and therapeutics with SEHTA’s MedTech and HealthTech expertise, covering the full breadth of life science SMEsEnhances BioUK’s support offerings with SEHTA’s broad membership network and competencies in market access and grant-fundi...

    Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS